CDK4/6 inhibitors for HR(+)HER2(-) early stage breast cancer - when to escalate treatment? Curigliano G. Nat Rev Clin Oncol 2020 Nov 24. pii: 10.1038/s41571-020-00453.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Curigliano G. CDK4/6 inhibitors for HR(+)HER2(-) early stage breast cancer - when to escalate treatment? Nat Rev Clin Oncol 2020 Nov 24. pii: 10.1038/s41571-020-00453.
PMID: 33235325